AdvanDx Launches First LNA-Based In Vitro Diagnostic Test For Detection Of Antibiotic Resistant “Superbugs”

AdvanDx, Inc. announced the launch of vanA/B EVIGENE in Europe, the first LNA-based in vitro diagnostic test for detecting the antibiotic resistant “Superbugs” Vancomycin-Resistant Enterococci (VRE) and Vancomycin-Resistant Staphylococcus aureus (VRSA) in positive blood cultures and clinical isolates. Infections with antibiotic resistant “Superbugs”, such as VRE and VRSA, are serious problems for patients and hospitals worldwide. [click link for full article]

More: continued here

Filed under: Infectious Diseases / Bacteria / Viruses on September 21st, 2007